Project Grant HT94252410907
Award Date
10/1/24
Completion Date
9/30/27
Dollars Obligated
$603K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Omaha, NE 68198, USA
Similar Awards
The Department of the Army Medical Command, through the Military Medical Research and Development federal grant program (CFDA 12.420), awarded a $556,200.00 project grant to the University of Nebraska Medical Center (UNMC) for "ADOPTIVE CELLULAR THERAPY FOR PANCREATIC CANCER". The award, with a period of performance from October 1, 2024 to September 30, 2027, will fund advanced biomedical research to develop innovative treatments for pancreatic cancer. UNMC, a prominent academic...
The Defense Health Agency awarded a $602,814 Project Grant to the University of Nebraska Medical Center (UNMC) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from November 1, 2024 to October 31, 2027, supports research to investigate "Targeting Extracellular Nucleoside Metabolism as a Strategy to Potentiate the Effects of Immunotherapy in Pancreatic Ductal Adenocarcinoma." The project aims to explore innovative approaches...
This $183,220 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research to target the CCL17/CCR4 axis in order to eradicate lung cancer brain metastasis. The primary awardee is the Board of Regents of the University of Nebraska, through its University of Nebraska Medical Center (UNMC) Division, a prominent academic research institution with extensive capabilities in biomedical research, medical...
The University of Nebraska Medical Center (UNMC) was awarded a $1,544,999.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on a "NOVEL ER STRESS MITIGATION PATHWAY IN ERBB2-DRIVEN ONCOGENESIS". The grant, which has a performance period from May 1, 2024 to April 30, 2027, will support UNMC's investigation of an innovative pathway for mitigating endoplasmic reticulum (ER) stress in ErbB2-driven...
The Department of the Army Medical Command awarded a $1.5 million Project Grant to the University of Nebraska Medical Center to support research targeting nuclear importins in pancreatic ductal adenocarcinoma (PDAC) under the Military Medical Research and Development program. The three-year award beginning July 1, 2022 will fund research exploring medical solutions for pancreatic cancer through investigation of nuclear transport proteins that mediate entry of molecules into the cell nucleus....
The Defense Health Agency awarded a $579,375 Project Grant to the University of Nebraska Medical Center to support research targeting APE1 interaction with DNA G-quadruplex to prevent metastasis in triple-negative breast cancer. The grant is funded through the Military Medical Research and Development program (CFDA 12.420) and aims to transform health care for service members and the public through innovative biomedical research investigating medical solutions for the battlefield. The University...
The Defense Health Agency awarded a $579,375 Project Grant to the University of Nebraska Medical Center through the Military Medical Research and Development program (CFDA 12.420) to support research targeting APE1 interaction with DNA G-quadruplex to prevent metastasis in triple-negative breast cancer. The three-year award beginning December 30, 2022 will fund research by the University of Nebraska Medical Center to investigate medical solutions for metastatic breast cancer through innovative...
The University of Nebraska Medical Center (UNMC) was awarded a $927,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research titled "TARGETING FGFR4 SIGNALING TO OVERCOME CHEMORESISTANCE IN OVARIAN CANCER". The grant has an award date of July 1, 2024 and an ultimate completion date of June 30, 2028. UNMC, a leading institution in health sciences education, innovative research, and patient care, will...
The Defense Health Agency awarded a $386,250 Project Grant to the University of Nebraska Medical Center through the Military Medical Research and Development program (CFDA 12.420) to support research targeting the validation and inhibition of RHNO1 function in ovarian cancer. The two-year award beginning July 1, 2023 will fund preclinical research efforts to investigate medical solutions for ovarian cancer at the molecular level. As the parent organization, the Board of Regents of the University...
This federal Project Grant award for $772,501.00, awarded on May 1, 2024 by the Defense Health Agency, supports the University of Nebraska Medical Center's research project titled "BUTYRYLCHOLINESTERASE: AN OUTSTANDING DIAGNOSTIC AND DRUGGABLE BIOMARKER IN UVEAL MELANOMA." The project, funded under the Military Medical Research and Development program (CFDA 12.420), aims to advance research into butyrylcholinesterase as a diagnostic and therapeutic target for uveal melanoma, a rare and...